Oxiracetam
| Oxiracetam | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 158.16 g/mol [1] |
| Predicted LogP | -2.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C6H10N2O3 |
| IUPAC name | 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide |
| SMILES | C1C(CN(C1=O)CC(=O)N)O |
| InChI | InChI=1S/C6H10N2O3/c7-5(10)3-8-2-4(9)1-6(8)11/h4,9H,1-3H2,(H2,7,10) |
| InChIKey | IHLAQQPQKRMGSS-UHFFFAOYSA-N |
| CAS number | 62613-82-5 |
| UNII | P7U817352G |
| PubChem CID | 4626 |
| Pharmacokinetics[] | |
|---|---|
| Onset | 30-90 Minutes |
| Elimination half-life | 8 hours |
| Excretion | Renal |
| Routes of administration | Oral, IV[3] |
Oxiracetam (also known as Isf-2522, Cgp 21690e, Oxiracetamum, Cgp-21690e, Gnf-pf-1005, N06bx07, 4-Hydroxy-2-oxopyrrolidine-N-acetamide, Hydroxypiracetam, 4-Hydroxy-2-oxo-1-pyrrolidineacetamide or Oxiracetam(Random Configuration)) is a antipsychotic substance of the racetam class.
Chemistry
Stereochemistry []
Oxiracetam is a racemic mixture of the enantiomers (optical activity ( + / - )).
Druglikeness
Lipinski's rule of five
Oxiracetam matches Lipinski's rule of five.Reagents
There are currently 6 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no color change | |
| Mecke | no color change | |
| Mandelin | clear | |
| Simon's | no blue color change | |
| Ehrlich | no color change | |
| Hofmann | no color change |
Pharmacology
ATC Classification
- nervous system (N)
- psychoanaleptics (N06)
- psychostimulants, agents used for adhd and nootropics (N06B)
- other psychostimulants and nootropics (N06BX)
- oxiracetam (N06BX07)
MeSH Classification
Legal status []
- Australia: Oxiracetam is a Schedule 4.
- United States: Oxiracetam is Unscheduled.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 4626, Oxiracetam. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/4626
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Oxiracetam. UNII: P7U817352G. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/P7U817352G
Oxiracetam for Injection, Package Insert. CSPC Pharmaceutical Group. https://www.e-cspc.com/upload/%E6%98%8E%E6%98%9F%E4%BA%A7%E5%93%81/files/%E6%B3%A8%E5%B0%84%E7%94%A8%E5%A5%A5%E6%8B%89%E8%A5%BF%E5%9D%A6.pdf
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 08:01:12 |
| drugspro | ok | 2026-11-20 08:01:08 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 08:01:08 |
| gsrs | ok | 2026-11-20 08:01:09 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0255986) | 2026-11-20 08:01:08 |
| kegg | ok | 2026-11-20 08:01:10 |
| pubchem | ok | 2026-11-20 08:01:07 |
| missing (no r/tripreports posts mention it) | 2026-11-20 08:01:08 | |
| sider | missing (not in SIDER) | 2026-11-20 08:01:08 |
| structure | ok | 2026-11-20 08:01:08 |
| wikipedia | ok | 2026-11-20 08:01:09 |